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Ghrelin is 28-amino-acid peptide that was discovered from the rat and human stomach in 1999. Since the discovery of ghrelin,
various functions of ghrelin, including growth hormone release, feeding behavior, glucose metabolism, memory, and also
antidepressant eﬀects, have been studied. It has also been reported that ghrelin in the gastrointestinal tract has an important
physiological eﬀect on gastric acid secretion and gastrointestinal motility. Ghrelin has a unique structure that is modiﬁed by O-
acylation with n-octanoic acid at third serine residues, and this modiﬁcation enzyme has recently been identiﬁed and named
ghrelin O-acyl transferase (GOAT). Ghrelin is considered to be a gut-brain peptide and is abundantly produced from endocrine
cells in the gastrointestinal mucosa. In the gastrointestinal tract, ghrelin cells are most abundant in the stomach and are localized
in gastric mucosal layers. Ghrelin cells are also widely distributed throughout the gastrointestinal tract. In addition, abundance of
ghrelin cells in the gastric mucosa is evolutionally conserved from mammals to lower vertebrates, indicating that gastric ghrelin
plays important roles for fundamental physiological functions. Ghrelin cells in the gastrointestinal tract are a major source of
circulating plasma ghrelin, and thus understanding the physiology of these cells would reveal the biological signiﬁcance of ghrelin.
1.Introduction
Severaldistincttypesofendocrinecells,includinghistamine-
producing ECL cells, somatostatin-producing D cells,
gastrin-producing G cells, and serotonin-producing EC
cells, have been shown to be present in the mammalian
stomach. Before the discovery of ghrelin, gastric ghrelin
cells were classiﬁed as unknown endocrine cells by their
round, compact, electron-dense secretory granules (P/D(1)-
type in humans, A-like-type in rodents, and X-type in dogs)
that distinguish them electron-microscopically from other
previously characterized gastric endocrine cell types [1, 2].
Ghrelin was identiﬁed as an endogenous ligand for growth
hormone secretagogue receptor (GHS-R) from the stomach
in 1999 [3]. Ghrelin structurally resembles motilin and they
share about 21% amino acid identity and their receptor
also has structural similarity with 44% similarity in amino
acids, indicating that they comprise a motilin-ghrelin family
[4, 5]. Interestingly, ghrelin was found to be present as
two molecular forms: acyl-ghrelin modiﬁed with medium
chain fatty acids and des-acylated-ghrelin lacking side chain
modiﬁcation [3, 6]. Although acyl-ghrelin is only known to
bind to GHS-R [7], accumulating results have shown that
des-acylated-ghrelin has various physiological functions via
unknown speciﬁc receptor, including involvement in cell
death, feeding behavior, and energy and glucose homeostasis
[8–13]. Moreover, in 2005, obestatin was identiﬁed as a
peptide hormone derived from preproghrelin in the stomach
[14] and obestatin has been shown to be involved in energy
homeostasis, gastrointestinal motility, memory, sleep, and
cell proliferation [13–18].
In this review, we focus on ghrelin cells in the gas-
trointestinal tract and describe the characteristic features,
development, and regulation of ghrelin cells.
2. Distribution and Morphological Features of
GhrelinCells inthe GastrointestinalTract
The distribution of ghrelin-producing cells in the gastroin-
testinal tract has been studied by using immunohistochem-
ical techniques and in situ hybridization [1, 2, 19, 20].2 International Journal of Peptides
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Figure 1: Localization of ghrelin-immunopositive cells in the stomach (rodents, avians, amphibians and ﬁsh). (a) Ghrelin cells in the rat
stomach. Ghrelin cells are mainly observed from the glandular base to the body of the fundic gland, and gastric ghrelin cells in the rat have
been clariﬁed to be closed-type cells. Ghrelin cells are scattered throughout the mucosal layer in (b) the proventriculus of the chicken and
(c) bullfrog stomach, and those ghrelin cells are also closed-type cells as rodents. (d) Ghrelin cells in the trout stomach are localized in the
mucosal layer, and both closed- and opened-type cells are found in the trout. Scale bars = 100μmi n( a ) ,( c ) ,( d ) ;3 0μmi n( b ) .
In rodents, ghrelin-producing cells were observed in all
regions of the gastrointestinal tract: gastric body, antrum,
duodenum, ileum, cecum, and colon. Ghrelin-producing
cells were most dense in the gastric body (Figure 1(a))a n d
were found in the mucosal layer but not in the myenteric
plexus in all of the examined regions. In the stomach,
most of the ghrelin cells were observed in the glandular
base decreasing in amount as the gland extends toward the
lumen with a few cells observed in the glandular neck. In
the duodenum, ileum, cecum, and colon, ghrelin cells were
scattered in the epithelia of crypts and villi. The densities of
ghrelin cells were dramatically decreased toward the lower
gastrointestinal tract [19]. The number of ghrelin-producing
cells in each gastrointestinal tract corresponded well with
the amount of peptide and mRNA expression levels [21].
In addition, plasma concentration of ghrelin in rats was
decreased by 80% after gastrectomy [1], and also plasma
ghrelin levels were reduced by 65% in human gastrectomised
patients, strongly suggesting that major source of circulating
plasma ghrelin is the gastric mucosa [22].
The morphological features of ghrelin-producing cells
in the stomach diﬀer from those of the intestinal tracts.
In the stomach, ghrelin-producing cells were found to be
small and round-shaped, so-called closed-type cells [1, 19,
23]. However, in the duodenum, ileum, cecum, and colon,
two types of ghrelin cells were found; that is, closed-type
cells with triangular or elongated shapes and opened-type
cells with their apical cytoplasmic process contacting to the
lumen. In general, opened-type cells are functionally regu-
lated by receiving luminal information such as nutrients and
pH, while closed-type cells are functionally modulated by
hormones, neuronal stimulation, or mechanical distension
[24]. Thus, the regulatory mechanisms of ghrelin release
would be diﬀerent in the stomach and other parts of the
gastrointestinal tract. By electron microscopic observation,
several groups have shown that immunogold labeling for
ghrelin was localized on the round and electron-dense
granules in gastric mucosal cells [2, 25–27]. Yabuki et al.
showed that the diameters of granules containing ghrelin
in mice (277.7 ± 11.1nm) and rats (268.8 ± 13.0nm)
were similar; however, those in hamsters (200.8 ± 8.8nm)
were signiﬁcantly smaller than those in mice or rats [26].
Rindi et al. demonstrated that mouse and canine ghrelin-
immunoreactive cells closely resembled those of the human
stomach, though it has been shown that dog ghrelin cells
have obviously larger granules (mean diameter of 273 ±
49nm) than those of rats (mean diameter of 183 ± 37nm)
and humans (147 ± 30nm) [27].
Localization of GOAT (Ghrelin O-Acyltransferase) and
ghrelin was also recently studied by using in situ hybridiza-
tion histochemistry and immunohistochemistry, and a high
degree of colocalization of GOAT and ghrelin was observed
in mouse gastric oxyntic mucosal cells [28]. On the other
hand, ghrelin-GFP transgenic mice expressing humanized
Renilla reniformis green ﬂuorescent protein (hrGFP) under
control of the mouse ghrelin promoter has recently beenInternational Journal of Peptides 3
generated and it has been conﬁrmed that hrGFP expression
was especially abundant in the gastric oxyntic mucosa, in
a pattern mirroring that of ghrelin immunoreactivity and
ghrelin mRNA [28].
3. Relationship of GhrelinandMotilinCells
Motilin was originally isolated from porcine intestinal
mucosa in the 1970s [29, 30]. Motilin is 22-amino-acid
peptide and it is known to play an important role for
the interdigestive migrating motor complex (MMC) [31].
Ghrelin and motilin and their receptors have similar struc-
tures and these two peptides are known to form a motilin-
ghrelin peptide family [5, 32]. It has been demonstrated
that ghrelin stimulates gastrointestinal motility in rodents,
suggesting that a part of the physiological eﬀects of these
two peptides is also overlapped. The distributions of ghrelin
andmotilincellsareseparated;motilinismainlyproducedin
the upper intestine, but ghrelin cells are localized mainly in
the stomach. Recently, Wierup et al. demonstrated that over
90% of ghrelin cells in the porcine duodenum coexpressed
motilin, and they also observed by electron microscopic
immunolabeling that they were localized on the same
secretory granules, indicating that they were cosecreted with
the same stimulation [33]. On the other hand, sequences
of ghrelin and motilin in the house musk shrew were
determined, and no coexistence of ghrelin and motilin was
found in gastric and duodenal cells [34, 35]. Therefore,
further studies are needed to elucidate the coexistence of
ghrelinandmotilin in onecellbyusing otheranimalmodels.
4.Development ofGhrelinCellsinthe
GastrointestinalTract
Ghrelin was found to be expressed in the fetal stomach from
embryonic day 18 and the number of fetal gastric ghrelin
cells increased as the stomach grew, with gastric ghrelin
content also increasing with advance of age [36]. Detailed
study showed that ghrelin-immunopositive cells appeared
in the glandular base of the fundic gland at 1 week of age
and they were found in the glandular base and the glandular
neck at 3 weeks of age. Then the distribution of ghrelin cells
was extended from the glandular base to the glandular neck
during the postneonatal developmental period [37]. Walia et
al. have also reported that ghrelin-immunoreactive cells were
rare at embryonic day 21 and that their number increased
progressively until weaning [38]. Gastric ghrelin mRNA
levels also increased in an age-dependent manner similar
to the number of ghrelin cells [36, 37, 39]. In addition,
ghrelin cells in female rats diﬀerentiated at an earlier stage
of development than that in male rats, and the density of
ghrelin cells in female rats was also higher than that in male
rats [37]. In humans, plasma ghrelin level was also higher in
females than in males [40].
5. Distribution and Features of Ghrelin Cells in
Nonmammalian Vertebrates
Ghrelin has been characterized not only in mammals
but also, many other species, avians, amphibians, reptiles,
and ﬁsh, and it has been shown that the structures of
ghrelin peptide were well preserved from mammals to
lower vertebrates [41]. The N-terminal regions of the ﬁrst
seven amino acids in lower vertebrates were well conserved,
and the third serine or threonine residue is modiﬁed
with medium chain fatty acid, mainly octanoic acid, as in
mammals [41]. In nonmammalians, it has been conﬁrmed
that ghrelin mRNA is abundantly expressed in the stomach
[42–48]. In avians, ghrelin-immunopositive cells were found
in the mucosal layer of the proventriculus (Figure 1(b)) that
corresponds to a ﬁrst glandular part of the stomach in which
digestive enzymes are mixed with food before the gizzard
[49]. However, ghrelin immunoreactivity in avians was not
located in the myenteric plexus, and many more ghrelin-
immunopositive cells were found in the middle layer than
in the base of the mucosal layer, with the majority of ghrelin
cells being round-shaped and closed-type cells [49]. Features
of gastric ghrelin cells in amphibians and reptiles are similar
to mammals or avian ghrelin cells. Ghrelin cells in these
animals were also found in the gastric mucosal layer but not
in the myenteric plexus or muscle layers of the stomach, and
the ghrelin cells are closed-type cells in frogs (Figure 1(c))
and turtles [45, 50]. Ghrelin cells in rainbow trout were
found to be localized as closed-type cells and opened-type
cells in the gastric mucosa (Figure 1(d))[ 51].
6. Regulation of GhrelinCellsin the
GastrointestinalTract
6.1. Ghrelin Cells on Fasting. Ghrelin is a potent orexigenic
peptide that stimulates food intake and body weight gain,
suggesting that ghrelin plays an important role in energy
homeostasis.Numerousdatahaveshownthatplasmaghrelin
levels were elevated in a fasting state and returned to basal
levels after refeeding [32, 52, 53]. On the other hand,
peptide content of ghrelin in the stomach decreased after
fasting [54], indicating that cytoplasmic ghrelin released
fromgastricghrelincellscausedanincreaseinplasmaghrelin
levels. Compared to biochemical analysis, studies on changes
in the number and staining property of gastric ghrelin
cells in a fasting state are quite restricted. For example,
the number of ghrelin-immunopositive cells signiﬁcantly
increased in rats during fasting for 7 days, and then the
cell number decreased to a normal level after refeeding
[55]. In bullfrogs, no signiﬁcant diﬀerences in numbers of
ghrelin cells were observed during fasting for 20 days [50].
Moreover, in ﬁsh fasted for 72 hours, Govoni et al. found no
clear diﬀerences in ghrelin cell numbers and their immuno-
staining intensity [18, 30, 56]. Therefore, further studies are
needed to elucidate the number of ghrelin cells in a multiple
time point study during a fasting period.
6.2. Ghrelin and Nutrients. As mentioned above, ghrelin
is known to be a hunger signal from peripheral tissues,
and plasma ghrelin levels drop to basal levels after a meal,
suggesting that ghrelin cells are regulated by nutrient uptake.
It has been reported that oral and intravenous glucose
administration sharply reduced plasma ghrelin concentra-
tion in rodents [53, 57], and this eﬀect of glucose on ghrelin4 International Journal of Peptides
inhibition was similar to that found in human studies [58–
61]. Williams et al. studied the eﬀect of intragastric load of
glucose on plasma ghrelin levels, and they found that plasma
ghrelin level was reduced by approximately 50% under a
normal gastric emptying condition [62]. On the other hand,
p l a s m ag h r e l i nl e v e l sw e r en o tc h a n g e di np y l o r i cc u ﬀ-
implanted rats, indicating that ghrelin release from gastric
ghrelin cells is aﬀected by glucose that is absorbed from the
intestine [62]. In addition to glucose, duodenal and jejunal
infusions of lipids or amino acids reduced ghrelin levels
in rats [63]. These eﬀects have been conﬁrmed in human
studies; free fatty acids or protein administration decreased
plasma ghrelin levels [64, 65]. However, the mechanisms by
which these nutrients regulate on gastric ghrelin release in
the stomach remain unclear. Further studies are needed to
elucidate the molecular pathway of ghrelin cell regulation by
nutrients.
6.3. Hormonal Control of Gastric Ghrelin. Ghrelin is also
regulated by circulating and gastric hormones. Ghrelin cells
are located close to somatostatin-producing D cells [66], and
somatostatin inhibits ghrelin secretion in rats and humans
[66–69]. Intravenous administration of glucagon caused
transient increases in both acyl- and des acyl-ghrelin levels.
Moreover, ghrelin secretion from the perfused stomach
was stimulated by glucagon treatment in a dose-dependent
manner [70], and this eﬀect was shown to be mediated by
glucagon receptors on ghrelin cells [71]. de la Cour et al.
performed a microdialysis study to ﬁnd a possible ghrelin
regulator in the stomach, and they found that epinephrine,
norepinephrine, endothelin, and secretin stimulated ghrelin
release [69].
Steroid hormone is also involved in ghrelin regulation.
A role of estrogen in the regulation of gastric ghrelin has
also been suggested by several studies. In humans, estrogen
regulates plasma ghrelin concentration [72–75]. The levels
of gastric ghrelin mRNA and plasma ghrelin and the number
of ghrelin cells were found to be transiently increased by
ovariectomyinfemalerats[76].Treatmentofgastricmucosal
cells with estrogen showed that estrogen stimulated ghrelin
expression and ghrelin secretion [77, 78]. These ﬁndings
indicate that gastric estrogen plays an important role in the
regulation of gastric ghrelin at the transcriptional level.
7.GhrelinCellsinthe DigestiveDiseases
In addition to the physiological, biochemical, and struc-
tural studies of ghrelin, pathological aspects of ghrelin
have been studied in various diseases, such as anorexia
nervosa,PraderWilliSyndrome(PWS),PolycysticSyndrome
(PCOS), and Celiac Disease (CD) [79–84] .T h er o l eo f
ghrelin in Helicobacter pylori (H. pylori) infections, gastric
diseasessuchaschronicgastritis,gastricandduodenalulcers,
and gastric carcinomas, has been widely studied. While there
are conﬂicting results, many papers have shown that plasma
ghrelin concentrations in the H. pylori positive subjects were
lower than in H. pylori negative subjects [85–87]. When
correlated with the plasma ghrelin levels, the number of
ghrelin immunopositive cells was signiﬁcantly lower in H.
pylori positive subjects than in negative subjects [85, 88].
Furthermore, ghrelin mRNA expression levels were also
lower in H. pylori-infected human subjects [88]. Using
Mongolian gerbils as an animal model of H. pylori infection,
Suzuki et al. showed that ghrelin mRNA expression levels
were signiﬁcantly lower in animals with H. pylori, compared
to control animals [89]. Furthermore, the number of ghrelin
immunopositive cells decreased in H. pylori-infected groups
17 and 23 weeks after infection, while the total number of
gastricmucosalcellsremainedunchanged.Inaddition,when
compared to control animals, gastric ghrelin contents were
signiﬁcantly decreased in infected animals 17 and 23 weeks
after H. pylori inoculation, although no diﬀerences were
detected after only four weeks. Notably, ghrelin cells in the
gastric mucosa are located close to the parietal cells, and
some of these cells are found to be in contact with each other
[77, 89], and it has been reported that H. pylori aﬀected the
function of parietal cells [90, 91]. Although further studies
are needed to elucidate the biological mechanisms behind
the regulation of gastric ghrelin after H. pylori infection,
it is possible that gastric estrogen, which is produced in
parietal cells, could aﬀect ghrelin cells in a paracrine manner.
Alternatively, inﬂammatory factors may act directly on
ghrelin cells to decrease their activity.
8. Conclusions
Ghrelin is predominantly produced in the stomach, and
gastric ghrelin is thought to play important multiple
physiological roles in peripheral signaling. Results of the
analysis of ghrelin cells in the gastrointestinal tract have
been accumulating. Many factors including nutrients as
well as circulating and gastric hormones were found to
be involved in the regulation of mRNA and release of
ghrelin, indicating that ghrelin cells are under the control
of complicated mechanisms, which are still obscure. In
addition, characteristics of ghrelin cells in the stomach and
other parts of the gastrointestinal tract are diﬀerent; closed-
type ghrelin cells are localized in the stomach and many
opened-type ghrelin cells are localized throughout the small
and large intestines. Since the length of the gastrointestinal
tract is long, considerable amounts of plasma ghrelin can
be assumed to be derived from ghrelin cells in small and
large intestines. Further studies are needed to understand the
physiological and pathological roles of ghrelin cells in both
small and large intestines. Moreover, posttranscriptional
modiﬁcations are very important for physiological active
ghrelin, necessitating the need to understand how GOAT
is involved in the regulation of ghrelin biosynthesis and
consequently may be important for controlling ghrelin cells
in some physiological states.
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